Cost-Effectiveness of Using Brentuximab Vedotin in Patients with Recurrent Hodgkin Lymphoma or Refractory to Transplant
Romero Prada, ME, Roa Cardenas, NC, Vasquez Melo, EC, Acero, G, Huerfano, LM, de Los Rios de Acevedo, MVolume:
19
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2016.09.2214
Date:
November, 2016
File:
PDF, 67 KB
english, 2016